Abstract

European Congress of Clinical Microbiology & Infectious Diseases 2021

Highlights

  • A collective response and collaborative efforts between policymakers and researchers are urgently needed to combat the growing threat of antimicrobial resistance

  • A panel co-organised by WHO discussed the scale of the threat of antimicrobial resistance, and ways to address the gaps between policy and research

  • Global manufacturers, including those in the food industry have a role to play; Robert Baker (Mars, McLean, VA, USA) commented that antimicrobial resistance is not typically perceived as a food safety issue, resistance is linked to antimicrobials used in the food supply chain and in the home; some are becoming less effective in treating infections and there is evidence linking resistance with hypervariability in pathogens creating so-called superbugs

Read more

Summary

Introduction

European Congress of Clinical Microbiology & Infectious Diseases 2021 A collective response and collaborative efforts between policymakers and researchers are urgently needed to combat the growing threat of antimicrobial resistance. A panel co-organised by WHO discussed the scale of the threat of antimicrobial resistance, and ways to address the gaps between policy and research.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.